Top Markets
#1 Seeker Seeker +53.94%
#2 Helium Helium +51.36%
#3 Pons Pons +32.13%
#4 UnifAI Network UnifAI Network +31.40%
#5 VVS Finance VVS Finance +23.84%
#6 Zylo Ecosystem Zylo Ecosystem +23.74%
#7 TENDIES TENDIES +22.70%
#8 Bounce Bounce +17.09%
#9 Songbird Songbird +15.39%
#10 DAPPOS DAPPOS +14.30%
Coin of the day
Seeker Seeker
Settings
Language
ENGLISH
Currency
USD
Theme
Sirio Pharma Co., Ltd. Sirio Pharma Co., Ltd.

Sirio Pharma Co., Ltd.

300791
Rank in Stocks #10817
Established in 1993 and headquartered in Shantou, China, Sirio Pharma Co., Ltd.... Established in 1993 and headquartered in Shantou, China, Sirio Pharma Co., Ltd. serves as a global contract manufacturer. The company is dedicated to producing a broad spectrum of dietary supplements, encompassing traditional and vegetarian softgels, a wide range of nutraceutical gummies, probiotic formulations, tablets, powders, capsules, and functional beverages. Beyond manufacturing, Sirio Pharma also offers complete primary and final packaging solutions to its customers.
Share Price
$2.54
Last synced: 2026-08-28
Market Cap
$784.63M
Change (1 day)
0.98%
Change (1 year)
-30.82%
Country
CN
Trade Sirio Pharma Co., Ltd. (300791)

Category

Consumer Defensive
P/B ratio for Sirio Pharma Co., Ltd. (300791)
P/B ratio as of 2026 TTM: 0
According to Sirio Pharma Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Sirio Pharma Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Nestlé S.A. Nestlé S.A.
Nestlé S.A.
NESN.SW
 7.131 -
CH
Danone S.A. Danone S.A.
Danone S.A.
BN.PA
 - -
FR
Ajinomoto Co., Inc. Ajinomoto Co., Inc.
Ajinomoto Co., Inc.
2802.T
 - -
JP
Nestlé India Limited Nestlé India Limited
Nestlé India Limited
NESTLEIND.NS
 56.0729 -
IN
JBS S.A. JBS S.A.
JBS S.A.
JBSS3.SA
 - -
BR